PTGS2 and depressive disorder: Compared with the depression group, the miR-301b inhibitor and SN50 groups demonstrated reduced levels of TNF-α, IL-Iβ and COX-2 (p < 0.05), and opposite trends were observed in the miR-301b mimic group (p < 0.05).